Skip to main content

Table 1 Clinical values at baseline and 1-year follow-up

From: Correlation of active contact location with weight gain after subthalamic nucleus deep brain stimulation: a case series

 

Baseline

1-year Follow-up

p-value

Bodyweight

55.8 (49.7–63.6)

60.7 (53.1–69.6)

< 0.001

BMI

23.1 (20.1–25.7)

24.5 (22.0–29.1)

< 0.001

UPDRS part III (MedOn)

14 (10–18)

8 (4.5–19.3)

0.13

UPDRS part III (MedOff)

40 (33.8–44.3)

16 (11.8–23)

< 0.001

UPDRS part IV (items 32 + 33)

1.5 (0–4)

1 (0–2.25)

0.12

MMSE

29 (27.8–30)

29 (28–30)

0.3

FAB

14.5 (14.5–17.5)

15.5 (13.8–17.3)

0.023

Apathy scale

13.5 (7.5–16)

14 (4.8–16.3)

0.47

PHQ-9

5 (4–8)

4 (0–7.8)

0.43

LEDD

689 (363–748.5)

418.5 (297.3–656.3)

0.085

  1. Scores are reported as the median (interquartile range)
  2. BMI body mass index; FAB Frontal Assessment Battery; LEDD levodopa-equivalent daily dose; MedOff a condition without intaking medication; MedOn a condition requiring intaking medication. MMSE Mini Mental State Examination; PHQ-9 Patient Health Questionnaire-9; UPDRS Unified Parkinson’s Disease Rating Scale